Dr. Peter Tsai, MD, PhD
Claim this profileStudies Autism Spectrum Disorder
1 reported clinical trial
1 drug studied
Clinical Trials Peter Tsai, MD, PhD is currently running
More about Peter Tsai, MD, PhD
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Peter Tsai, MD, PhD has experience with
- TDCS
Breakdown of trials Peter Tsai, MD, PhD has run
Autism Spectrum Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Tsai, MD, PhD specialize in?
Peter Tsai, MD, PhD focuses on Autism Spectrum Disorder and other conditions. In particular, much of their work with Autism Spectrum Disorder has involved treating patients, or patients who are undergoing treatment.
Is Peter Tsai, MD, PhD currently recruiting for clinical trials?
Yes, Peter Tsai, MD, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Peter Tsai, MD, PhD has studied deeply?
Yes, Peter Tsai, MD, PhD has studied treatments such as tDCS.
What is the best way to schedule an appointment with Peter Tsai, MD, PhD?
Apply for one of the trials that Peter Tsai, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.